TDC
ASMB icon

Thompson Davis & Co’s Assembly Biosciences ASMB Stock Holding History

Thompson Davis & Co’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10
Closed -$6K – 666
2018
Q1 		$6K Hold
10
– – 0.02% 459
2017
Q4 		$6K Sell
10
-32
-76% -$14.5K 0.01% 487
2017
Q3 		$17K Buy
+42
New +$12.9K 0.03% 521
2017
Q2 		– Sell
-260
Closed -$80K – 1075
2017
Q1 		$80K Buy
260
+197
+313% +$48.3K 0.11% 171
2016
Q4 		$9K Sell
63
-1,169
-95% -$174K 0.01% 716
2016
Q3 		$107K Buy
1,232
+1,190
+2,833% +$91.9K 0.19% 120
2016
Q2 		$3K Buy
+42
New +$2.76K ﹤0.01% 873
2015
Q3 		– Sell
-10
Closed -$2K – 1128
2015
Q2 		$2K Buy
+10
New +$1.93K ﹤0.01% 1067

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's ASMB Position: Q2 2018 in Review

Thompson Davis & Co sold out of Assembly Biosciences (ASMB) in Q2 2018, closing a stake of 10 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in ASMB in Q2 2015 and held it in 8 quarters. The position peaked at $107K in Q3 2016. 105 funds tracked by Wall St. Rank hold ASMB as of Q2 2018.

  • Thompson Davis & Co reported no remaining Assembly Biosciences position as of Q2 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 10 Assembly Biosciences shares in Q2 2018, an estimated $6K.
  • Thompson Davis & Co first reported a position in Assembly Biosciences in Q2 2015 and held it in 8 quarters.
  • Thompson Davis & Co's Assembly Biosciences position peaked at $107K in Q3 2016.
  • 105 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.